Recurrent Clostridium Difficile Disease: Epidemiology and Clinical Characteristics
- 2 January 1999
- journal article
- clinical trial
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 20 (1), 43-50
- https://doi.org/10.1086/501553
Abstract
Objective: : To describe the epidemiology, diagnosis, risk factors, patient impact, and treatment strategies for recurrentClostridium difficile-associated disease (CDAD).Design: : Data were collected as part of a blinded, placebo-controlled clinical trial testing a new combination treatment for recurrent CDAD. Retrospective data regarding prior CDAD episodes were collected from interviews and medical-chart review. Prospective data on the current CDAD episode, risk factors, and recurrence rates were collected during a 2-month follow-up.Settings: : National referral study.Participants: : Patients with recurrent CDAD.Interventions: : Treatment with a 10-day course of low-dose (500 mg/d) or high-dose (2 g/d) vancomycin or metronidazole (1 g/d).Results: : Recurrent CDAD was found to have a lengthy course involving multiple episodes of diarrhea, abdominal cramping, nausea, and fever. CDAD may recur over several years despite frequent treatment with antibiotics. Recurrence rates were similar regardless of the choice or dose of antibiotic. Recurrent CDAD is not a trivial disease: patients may have multiple episodes (as many as 14), may require hospitalization, and the mean lifetime cost of direct medical care was $10,970 per patient. Fortunately, the disease does not become progressively more severe as the number of episodes increase. Two risk factors predictive for recurrent CDAD were found: increasing age and a decreased quality-of-life score at enrollment.Conclusions: : Recurrent CDAD is a persistent disease that may result in prolonged hospital stays, additional medical costs, and rare serious complications.Keywords
This publication has 43 references indexed in Scilit:
- Clostridium difficile infection as a cause of severe sepsisIntensive Care Medicine, 1996
- Comparison of Vancomycin, Teicoplanin, Metronidazole, and Fusidic Acid for the Treatment of Clostridium difficile--Associated DiarrheaClinical Infectious Diseases, 1996
- Whole-Bowel Irrigation As an Adjunct to the Treatment of Chronic, Relapsing Clostridium Difficile ColitisJournal of Clinical Gastroenterology, 1996
- Chronic septic arthritis and osteomyelitis in a prosthetic knee joint due toClostridium difficileEuropean Journal of Clinical Microbiology & Infectious Diseases, 1995
- Evaluation of a commercial enzyme immunoassay kit for the detection ofClostridium difficile toxin AEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Loperamide related toxic megacolon in Clostridium difficile colitisHeart, 1990
- Clostridium difficile-Associated Diarrhea After NorfloxacinJournal of Clinical Gastroenterology, 1990
- Nosocomial Acquisition ofClostridium difficileInfectionThe New England Journal of Medicine, 1989
- Clostridium difficile: The epidemiology and prevention of hospital-acquired infectionInfection, 1982
- Relapse of Pseudomembranous Colitis after Vancomycin TherapyThe New England Journal of Medicine, 1979